Quick Takeaways
- UBS Group AG filed SCHEDULE 13G/A for Renalytix plc Ordinary shares, nominal value 0.0025 per share (RNLXY).
- Disclosed ownership: 0%.
- Date of event: 31 Dec 2024.
UBS Group AG - 31 Dec 2024 SCHEDULE 13G/A Report for Renalytix plc Ordinary shares, nominal value 0.0025 per share (RNLXY)
- Filing Manager
- UBS Group AG
- Reporting Manager
- UBS Group AG
- Symbol
- RNLXY
- Disclosed Ownership
- 0 shares
- Ownership
- 0%
- Form type
- SCHEDULE 13G/A
- Filing time
- 30 Apr 2025, 16:15:21 UTC
- Date of event
- 31 Dec 2024
- Next filing
- 30 Apr 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"UBS Group AG disclosed 0% ownership in Renalytix plc Ordinary shares, nominal value 0.0025 per share (RNLXY) on 31 Dec 2024."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 30 Apr 2025, 16:15.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| UBS Group AG | 0% | 0 | 0 | 0 | ANDREW JOHNSON | DIRECTOR |